Menu

The Procter & Gamble Company (PG)

$142.17
-1.14 (-0.80%)
Get curated updates for this stock by email. We filter for the most important fundamentals-focused developments and send only the key news to your inbox.

Data provided by IEX. Delayed 15 minutes.

Market Cap

$333.0B

Enterprise Value

$357.8B

P/E Ratio

19.9

Div Yield

2.91%

Rev Growth YoY

+0.3%

Rev 3Y CAGR

+1.7%

Earnings YoY

+7.4%

Earnings 3Y CAGR

+2.7%

Company Profile

At a glance

The Perfect Storm is Here: Procter & Gamble's Q1 FY26 results reveal simultaneous assaults on its core strategy—heightened competitive promotion eroding market share (down 30bps globally), consumer consumption decelerating to 1.5-2% from 3% historical norms, and margin compression (gross margin -70bps) from tariffs and commodity costs, testing whether its integrated superiority model can deliver in a defensive consumer environment.

Innovation as the Only Defense: Management is doubling down on superiority through breakthrough launches like Tide evo (the biggest liquid upgrade in 20 years) and Oral-B iO10, with five brands in Circana's top 25 new products. This matters because premium innovation is the only lever left to justify pricing power—without it, the entire margin structure collapses under $500M in tariff headwinds and $100M in commodity pressures.

Restructuring: A $2 Billion Bet on Agility: The planned 7,000-job reduction (15% of non-manufacturing workforce) and $1.5-2B restructuring program represents PG's first major organizational overhaul in years. This signals recognition that legacy overhead is now a competitive liability, but execution risk is material—unrealized savings could mean destroyed value rather than reinforced competitiveness.

Price Chart

Loading chart...